BMI-1026
BMI-1026 is a cyclin-dependent kinase 1 (Cdk1) inhibitor with IC50 of 2.3 nM. BMI-1026 induces apoptosis by arresting the G2-M phase[1].
Product Specifications
CAS Number
477726-77-5
UNSPSC
12352005
Target
Apoptosis; CDK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bmi-1026.html
Smiles
OC1=CC=C(C=C1C2=NC(N)=NC=C2)C3=NC(N)=NC=C3
Molecular Formula
C14H12N6O
Molecular Weight
280.28
References & Citations
[1]Seong YS, et al. Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026. Cancer Res. 2003 Nov 1;63 (21) :7384-91. Erratum in: Cancer Res. 2004 May 15;64 (10) :3725.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP7821-01 10 µg
Recombinant Human Frizzled-10 / FZD10 Protein (His tag)
Sign In for Pricing
View Details ARP7821-02 50 µg
Recombinant Human Frizzled-10 / FZD10 Protein (His tag)
Sign In for Pricing
View Details ARP7821-03 100 µg
Recombinant Human Frizzled-10 / FZD10 Protein (His tag)
Sign In for Pricing
View Details ARP7821-04 1 mg
Recombinant Human Frizzled-10 / FZD10 Protein (His tag)
Sign In for Pricing
View Details MBS1252195-01 0.02 mg (E-Coli)
Recombinant Synechocystis sp. Phosphoribosylamine--glycine ligase (purD)
Sign In for Pricing
View Details MBS1252195-02 0.02 mg (Yeast)
Recombinant Synechocystis sp. Phosphoribosylamine--glycine ligase (purD)
Sign In for Pricing
View Details